Sunshine Biopharma Inc. (SBFMW)
2025-06-30 | ||||
|---|---|---|---|---|
| Revenue | 9,410,230 | |||
| Cost of sales | 5,987,364 | |||
| Gross profit | 3,422,866 | |||
| Salaries | 2,048,676 | |||
| R&d | 196,232 | |||
| Accounting | 75,611 | |||
| Consulting | 736,727 | |||
| Office | 806,605 | |||
| Director fees | 100,000 | |||
| Marketing | 201,658 | |||
| Legal | 64,995 | |||
| Impairment of intangible assets | 1,061,809 | |||
| Depreciation | 72,533 | |||
| Taxes | 112,675 | |||
| Total general & administrative expenses | 5,477,521 | |||
| (loss) from operations | -2,054,655 | |||
| Interest income | 72,715 | |||
| Interest expense | - | |||
| Foreign exchange gain | 1,940 | |||
| Total other income (expense) | 74,655 | |||
| Net (loss) before income taxes | -1,980,000 | |||
| Provision for income taxes | -209,166 | |||
| Net (loss) | -1,770,834 | |||
| Gain (loss) from foreign exchange translation | 1,084,557 | |||
| Comprehensive (loss) | -686,277 | |||
| Basic (loss) per common share | -0.39 | |||
| Earnings per share, diluted | -0.82 | |||
| Weighted average common shares outstanding (basic ) | 4,496,108 | |||
| Weighted average number of shares outstanding, diluted | 3,604,653 | |||